ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹470 Cr | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr |
What is the latest Total Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹470 Cr |
| Mar2024 | ₹439 Cr |
| Mar2023 | ₹1,015 Cr |
| Mar2022 | ₹747 Cr |
| Mar2021 | ₹1,445 Cr |
How is Total Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹470 Cr | 7.15 | |
| Mar2024 | ₹439 Cr | -56.77 | |
| Mar2023 | ₹1,015 Cr | 35.90 | |
| Mar2022 | ₹747 Cr | -48.32 | |
| Mar2021 | ₹1,445 Cr | - | |
Compare Total Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹13,133.8 Cr | 1.4% | 2.4% | -1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 1.4% |
2.4% |
-1.3% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses